Phase II b Study of Immunogenicity and Safety of Flubio Vaccine in Infants and Children
Phase of Trial: Phase II/III
Latest Information Update: 15 Mar 2018
Price : $35 *
At a glance
- Drugs Influenza HA vaccine (Flubio) (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms Bridging
- Sponsors PT Bio Farma
- 15 Mar 2018 Results assessing immunogenicity and safety published in the Vaccine
- 28 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2014 Planned End Date changed from 1 Aug 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.